Safety of incobotulinumtoxinA in pediatrics: A pooled analysis
Objective: To present analyses of pooled data on the safety of incobotulinumtoxinA (INCO) in pediatrics Background: BotulinumtoxinA (BoNT-A) is used to treat several conditions affecting…Predicting the development of dementia in patients with Parkinson’s disease by comparing neurosteroids in the blood level
Objective: To increase the reliability of the development of dementia in patients with PD by a comparative assessment of clinical scales and neurosteroids Background: Parkinson's…Speech markers of Presymptomatic and Prodromal Huntington’s disease
Objective: To investigate the sensitivity of digital speech measures for detecting subtle cognitive-linguistic and fine motor features in people carrying the expanded HD gene, with…Study of retinal and optic nerve ganglion cell layer in Parkinson’s disease and asymptomatic carriers of the LRRK2-G2019S mutation
Objective: To study whether retinal nerve alterations can be a useful biomarker in presymptomatic stages of Parkinson's disease (PD) associated with the G2019S mutation of…Frequency of depression and predictors of mood change among caregivers of Parkinson’s disease patients
Objective: The aim of the present study was to analyze the frequency of depression in a cohort of caregivers of patients with Parkinson ́s disease…Cognitive behavioral therapy for anxiety in Parkinson’s disease induces functional brain changes
Objective: To identify changes in functional connectivity in the brain after cognitive behavioral therapy (CBT) for anxiety in patients with Parkinson's disease (PD). Background: CBT…Using quantitative susceptibility mapping and diffusion magnetic resonance imaging to identify structural features of early-stage Parkinson’s disease
Objective: To identify an imaging diagnostic biomarker of PD for use in clinics by applying structural magnetic resonance imaging (MRI) techniques. Background: The midbrain dopaminergic…Alprazolam reduces freezing of gait and improves freezing-related gait measures
Objective: We investigated the effect of acutely reducing anxiety with the benzodiazepine, Alprazolam, on freezing of gait (FOG) in patients with Parkinson’s disease (PD). Background:…Belly Dance Dyskinesia, a manifestation of B12 deficiency and hyperhomocysteinuria in MTHFR gene mutation. Videographic record of a case.
Objective: We present a case of probable Belly Dance Dyskinesia (BDD) secondary to vitamin B12 deficiency. Background: BDD is a rare movement disorder (considered a…Anosognosia in HD: Comparison of Self-report and Caregiver Ratings with Objective Performance Measures
Objective: Objective: To compare patient and caregiver report of cognitive, motoric, and psychiatric symptoms versus objective performance measures in patients with Huntington’s disease (HD). Background:…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.